Cancer
Methotrexate (antifolate)
A folic acid antagonist that inhibits dihydrofolate reductase: in high doses a cytotoxic drug for osteosarcoma and leukaemias; in low weekly doses an immunosuppressant for psoriasis, rheumatoid arthritis and Crohn disease.
Mécanisme d’action
- Methotrexate inhibits dihydrofolate reductase, so cells cannot regenerate tetrahydrofolate.
- Without it, thymidylate and purines cannot be made, and DNA synthesis stops in the S phase.
- In low doses it acts mainly by raising adenosine, which dampens inflammation, and by slowing keratinocyte and lymphocyte proliferation.
- Leucovorin (folinic acid) bypasses the block and rescues normal cells after high doses.
Cibles moléculaires
- Dihydrofolate reductase: Inhibitor
Médicaments : Methotrexate (antifolate)
- Methotrexate (Once weekly for psoriasis and arthritis; high dose with leucovorin rescue for osteosarcoma.)
- Pemetrexed (Antifolate used in non-squamous lung cancer.)
Indications thérapeutiques
- Osteosarcoma (high-dose methotrexate with cisplatin and doxorubicin)
- Moderate to severe psoriasis
- Rheumatoid and psoriatic arthritis
- Maintenance in Crohn disease (alternative to thiopurines)
- Acute lymphoblastic leukaemia
Maladies traitées
Effets indésirables
- Myelosuppression and mucositis
- Liver fibrosis and cirrhosis with long-term use
- Pneumonitis
- Kidney damage at high doses
- Teratogenicity
Contre-indications selon le terrain
- Pregnancy (Contre-indiqué): It is an abortifacient and causes birth defects; contraception is required.
- Liver cirrhosis (Contre-indiqué): It causes fibrosis and cirrhosis, more so in a damaged liver.
- Hepatic steatosis (fatty liver) (Avec précaution): Steatosis increases its liver toxicity.
- Severe kidney impairment (Contre-indiqué): It is excreted by the kidney and accumulates.
Autres précautions et interactions
- Taking it daily instead of weekly by mistake has caused deaths.
- Trimethoprim and NSAIDs raise its toxicity.
Rédigé d’après
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 35, Anticancer Drugs, Antimetabolites: methotrexate
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 43, Drugs for Dermatologic Disorders, Psoriasis
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 54, Cancer Chemotherapy, Antimetabolites
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 36, Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Nonopioid Analgesics, & Drugs Used in Gout, Methotrexate
Ressource pédagogique. Ne constitue pas un avis, un diagnostic ou un traitement médical.